pemphigus

(redirected from Pemphix)
Also found in: Thesaurus, Medical, Encyclopedia.

pem·phi·gus

 (pĕm′fĭ-gəs, pĕm-fī′gəs)
n.
Any of several acute or chronic skin diseases characterized by groups of itching blisters.

[New Latin pemphīgus, from Greek pemphīx, pemphīg-, pustule.]

pem′phi·gous adj.

pemphigus

(ˈpɛmfɪɡəs; pɛmˈfaɪ-)
n
(Pathology) pathol any of a group of blistering skin diseases, esp a potentially fatal form (pemphigus vulgaris) characterized by large blisters on the skin, mucous membranes of the mouth, genitals, intestines, etc, which eventually rupture and form painful denuded areas from which critical amounts of bodily protein, fluid, and blood may be lost. Also (obsolete): pemphix
[C18: via New Latin from Greek pemphix bubble]

pem•phi•gus

(ˈpɛm fɪ gəs, pɛmˈfaɪ-)

n.
a skin disease characterized by blisters and ulcerations.
[1770–80; < New Latin < Greek pémphīx (s. pemphīg-) bubble]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.pemphigus - a skin disease characterized by large thin-walled blisters (bullae) arising from normal skin or mucous membranepemphigus - a skin disease characterized by large thin-walled blisters (bullae) arising from normal skin or mucous membrane
autoimmune disease, autoimmune disorder - any of a large group of diseases characterized by abnormal functioning of the immune system that causes your immune system to produce antibodies against your own tissues
disease of the skin, skin disease, skin disorder - a disease affecting the skin
acantholysis - a breakdown of a cell layer in the epidermis (as in pemphigus)
Translations

pem·phi·gus

n. L. pénfigo, término usado para definir una variedad de dermatosis, cuya característica común consiste en la manifestación de ampollas que se infectan y revientan.

pemphigus

n pénfigo
References in periodicals archive ?
M2 PHARMA-June 17, 2019-Phase III PEMPHIX Study Showed That Genentech's Rituxan is Superior to Standard of Care in Achieving Sustained Remission in Patients with Pemphigus Vulgaris
Genentech, a member of the Roche Group, announced positive top line results from the Roche-sponsored Phase III PEMPHIX study evaluating the efficacy and safety of Rituxan compared to mycophenolate mofetil, or MMF, in adults with moderate to severe pemphigus vulgaris, or PV.
The Roche-sponsored phase III multicentre, randomised, double-blind PEMPHIX study, evaluating the efficacy and safety of MabThera compared with mycophenolate mofetil (MMF), an immunosuppressant, in patients with moderate to severe PV, is ongoing.